by admin | Nov 21, 2024 | News
Following months of sequential success in the Seedcorn competition, we are delighted to share that Klas Therapeutics was the Early Stage Regional Winner for Northern Ireland, a testament to our innovative work in transforming melanoma care through our patented...
by admin | Sep 16, 2024 | News
We are delighted to announce that Klas Therapeutics and our CEO, Prof. Bridgeen Callan, are among the 40 winners of the Women TechEU award. The program received over 800 applications from a range of deep tech female lead companies from across Europe. This EU funded...
by admin | Aug 30, 2024 | News
KlasTx is delighted to confirm that we have been selected as regional finalists in the InterTradeIreland Seedcorn competition 2024. The Seedcorn Investor Readiness Competition is designed for start-ups and early-stage businesses and is seen as the perfect chance to...
by admin | Feb 1, 2024 | News
Through the mentorship and guidance of the ICURe programme, KlasTx was awarded a circa £300,000 grant from Innovate UK. This grant allowed KlasTx to focus on preclinical developments which will aid in commercialisation pathway of our proprietary technology. This...
by admin | Oct 30, 2023 | News
Following a rigorous 3 stage competition, KlasTx receives the ‘Seal of Excellence’ from EIC.
